Clinical Trial Update: Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing Tigerase in complex therapy for COVID-19; completed study evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Tigerase®

Snippet

Sponsor: AO GENERIUM | Conditions: COVID-19, Coronavirus Disease 2019 | Phase 3 | Status: COMPLETED